Page last updated: 2024-11-06
nucleocidin
Description
nucleocidin: adenine nucleoside; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
nucleocidin : A nucleoside antibiotic that is 5'-O-sulfamoyladenosine in which the hydrogen atom at position 4' is replaced by a fluorine atom. It is a natural product synthesized by several Streptomyces species. It exhibits broad spectrum antibacterial activity, and also has a strong effect against Trypanosoma brucei, the protozoan parasite responsible for the African sleeping sickness. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 72299 |
CHEBI ID | 166872 |
SCHEMBL ID | 3978671 |
MeSH ID | M0046798 |
Synonyms (20)
Synonym |
nulceocidin |
antibiotic t-3018 |
nsc 521007 |
4'-c-fluoroadenosine 5'-sulfamate |
9-(4-fluoro-5-o-sulfamoylpentofuranosyl)adenine |
t-3018 |
adenosine, 4'-c-fluoro-, 5'-sulfamate |
CHEBI:166872 |
[(2s,3s,4r,5r)-5-(6-aminopurin-9-yl)-2-fluoro-3,4-dihydroxyoxolan-2-yl]methyl sulfamate |
4'-fluoro-5'-o-sulphamoyladenosine |
nucleocidin |
4'-fluoro-5'-o-sulfamoyladenosine |
[(2s,3s,4r,5r)-5-(6-aminopurin-9-yl)-2-fluoro-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl sulfamate |
f5097ng7jt , |
unii-f5097ng7jt |
SCHEMBL3978671 |
nucleocidin [mi] |
HY-100496 |
CS-0019532 |
Q27277644 |
Research Excerpts
Overview
Nucleocidin is an adenosine derivative containing 4'-fluoro and 5'-O-sulfamoyl substituents.
Roles (5)
Role | Description |
bacterial metabolite | Any prokaryotic metabolite produced during a metabolic reaction in bacteria. |
antibacterial agent | A substance (or active part thereof) that kills or slows the growth of bacteria. |
trypanocidal drug | A drug used to treat or prevent infections caused by protozoal organisms belonging to the suborder Trypanosomatida. |
protein synthesis inhibitor | A compound, usually an anti-bacterial agent or a toxin, which inhibits the synthesis of a protein. |
nucleoside antibiotic | null |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (5)
Class | Description |
adenosines | Any purine ribonucleoside that is a derivative of adenosine. |
organofluorine compound | An organofluorine compound is a compound containing at least one carbon-fluorine bond. |
sulfamate ester | |
6-aminopurines | Any compound having 6-aminopurine (adenine) as part of its structure. |
diol | A compound that contains two hydroxy groups, generally assumed to be, but not necessarily, alcoholic. Aliphatic diols are also called glycols. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 5 (33.33) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 5 (33.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 25.06
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 25.06 (24.57) | Research Supply Index | 2.89 (2.92) | Research Growth Index | 4.62 (4.65) | Search Engine Demand Index | 26.67 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (5.88%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 16 (94.12%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |